FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
CADILAHC Share Price Discussion
Cadila Healthcare Ltd.
NSE: CADILAHC | BSE: 532321 | ISIN: INE010B01027 | Sector: Pharmaceuticals and health care
Find answers to all your questions on live CADILAHC message board: Is CADILAHC buy or sell? Should I buy CADILAHC shares? Why are CADILAHC shares falling? Should I invest in CADILAHC stock?
You can also check CADILAHC share price target recommended by brokerages.
Recent posts in CADILAHC
@researcheducation • Reputation: -63,717
INTRADAY & POSITIONAL
CADILA BUY
ABOVE 272
STOP LOSS 267
TARGETS 276 280 284 ++
Like
reply
Reply
@newsbot • Reputation: 2,570
Cadila, Ipca gain 4-9% after US allows emergency use of antimalarial drugs for COVID-19
Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.
Cadila Healthcare and Ipca Labs are prominent manufacturers of hydroxychloroquine and chloroquine in India. Both are antimalarial drugs.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Cadila Healthcare share price rises over 2% on USFDA approval to Zydus for Parkinson's drug
The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.
The drug will be manufactured at the group’s manufacturing facility at SEZ, Ahmedabad.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,570
Zydus Cadila gets tentative nod from USFDA for Parkinson's treatment capsule
The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.
The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.
Moneycontrol
Like
reply
Reply
